Nineteen (13%) patients with normal ITPase activity underwent at least one dose reduction of RBV, whereas one (2%) patient with ITPase deficiency underwent at least one dose reduction (p = 0.014, Fig 2). The gene discussed is ITPA; the disease is hyperinsulinemic hypoglycemia, familial, 4.